Clinical Trials on Gaucher Disease Type 1 in New Zealand
Total 9569 results
-
Hoffmann-La RocheTerminatedLymphoma, Large B-Cell, Diffuse | Follicular LymphomaUnited States, Australia, Germany, Korea, Republic of, New Zealand
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...Sanofi; ModeX TherapeuticsTerminated
-
PfizerTerminatedHIV-1Spain, United Kingdom, Malaysia, United States, Portugal, Brazil, Germany, Italy, Poland, Puerto Rico, South Africa, Taiwan, Ukraine
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Gilead SciencesCompletedHIV-1 InfectionRussian Federation, United States, Thailand, Uganda, Puerto Rico, Dominican Republic
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | AsthmaUnited States, Slovakia, India, Malaysia, Australia, Former Serbia and Montenegro
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States, Puerto Rico
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionsUnited States
-
BioMarin PharmaceuticalTerminatedPompe DiseaseUnited States, United Kingdom, Australia, France, Germany, New Zealand
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers SquibbActive, not recruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11 Translocation CarcinomaAustralia
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Insmed IncorporatedMuscular Dystrophy AssociationCompleted
-
National Institute of Allergy and Infectious Diseases...Not yet recruitingPregnancy | HIV-1-infection | PostpartumUnited States, South Africa
-
PfizerCompletedHIV-1United Kingdom, South Africa, Australia, Canada, Italy, Poland, Switzerland, Argentina, Mexico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Italy, Canada, Denmark, Finland, Spain, Netherlands, Austria, Sweden, Belgium, France, Bulgaria, South Africa
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingJuvenile Myelomonocytic Leukemia | Neurofibromatosis Type 1United States
-
Jersey Shore University Medical CenterRutgers University; Rutgers Cancer Institute of New JerseyCompletedPancreatic Cancer | Parathyroid Disease | Thymic Cancer | MEN1 SyndromeUnited States
-
Hoffmann-La RocheActive, not recruitingMetastatic Melanoma | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Esophageal Squamous Cell Carcinoma (ESCC) | Small Cell Lung Cancer (SCLC)United States, Korea, Republic of, Denmark, France, Spain, New Zealand
-
Gilead SciencesCompletedHepatocellular Carcinoma | Hepatitis CUnited States, New Zealand, Spain
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)TerminatedHepatitis C | HIV-1 InfectionUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingHIV-1 InfectionUnited States, Australia, Canada, Chile, Colombia, France, Germany, Italy, Japan, New Zealand, Poland, Russian Federation, South Africa, Spain, Switzerland, United Kingdom
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingNeuroendocrine Tumors | Advanced Biliary Tract Cancer | Female Reproductive System Neoplasm | MSI-H Solid Malignant TumorNew Zealand, Australia
-
Trans Tasman Radiation Oncology GroupAustralasian Leukaemia and Lymphoma GroupCompletedFollicular LymphomaAustralia, New Zealand, Canada
-
TakedaCompletedNarcolepsy Type 1Spain, Japan, France, Germany, United States, Norway, Netherlands, Finland, Switzerland, Australia, Italy, Sweden
-
TakedaEnrolling by invitationAlpha1-Antitrypsin DeficiencyUnited Kingdom, Germany, United States, Austria, Portugal
-
PfizerTerminatedDiabetes Mellitus, Type 1United States, Canada, Brazil, Mexico, Argentina
-
Pharnext SACompletedPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)Charcot-Marie-Tooth Disease Type 1AUnited States, United Kingdom, Belgium, Canada, France, Netherlands, Spain, Germany
-
Pharnext S.C.A.Premier Research Group plc; Eurofins Optimed; Synteract HCR (Syneos Health); Gr... and other collaboratorsActive, not recruitingCharcot-Marie-Tooth Disease, Type IAUnited States, Belgium, Canada, France, Netherlands, Spain, United Kingdom
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHypertriglyceridemia | Steatohepatitis | Non Alcoholic Fatty Liver Disease | Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1United States
-
PfizerViiV HealthcareTerminatedHIV-1South Africa, Australia, United Kingdom, Canada, Italy, Poland, Switzerland, Mexico, Brazil
-
Montefiore Medical CenterThe Bee FoundationRecruitingAnxiety Depression | Mental Health Wellness 1 | Aneurysm CerebralUnited States
-
New York Institute of TechnologyAmerican Osteopathic AssociationRecruitingType2 Diabetes Mellitus | Osteopathy in Diseases Classified ElsewhereUnited States
-
NYU Langone HealthCompletedNeurofibromatosis Type 2 | Vestibular SchwannomasUnited States
-
Yale UniversityTerminatedPre-Eclampsia | Elevated Blood Pressure | Stage 1 HypertensionUnited States
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingAlpha-1 Antitrypsin DeficiencyUnited States, United Kingdom, Germany, Ireland
-
Bristol-Myers SquibbTerminatedHIV-1 InfectionThailand, United States, Australia, Canada, Spain, Colombia, South Africa, Hungary, France, Peru, Argentina, Chile, Mexico
-
PfizerNo longer availableGaucher DiseaseUnited States, Israel
-
NYU Langone HealthGlaxoSmithKlineCompletedNeurofibromatosis 2 | Vestibular SchwannomaUnited States
-
New York Stem Cell Foundation Research InstituteLaser and Skin Surgery Center of New YorkActive, not recruitingMacular Degeneration | Cancer | Diabetes Mellitus, Type 1 | Parkinson Disease | Alzheimer Disease | ALS | Huntington DiseaseUnited States
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID); National Institute...Completed
-
QIAGEN Gaithersburg, IncCompletedRespiratory Syncytial Virus Infections | Influenza A | Rhinovirus | Influenza B | QIAGEN ResPlex II Advanced Panel | Infection Due to Human Parainfluenza Virus 1 | Parainfluenza Type 2 | Parainfluenza Type 3 | Parainfluenza Type 4 | Human Metapneumovirus A/B | Coxsackie Virus/Echovirus | Adenovirus Types B/C/E | Coronavirus Subtypes 229E and other conditionsUnited States
-
Boston TherapeuticsSugardown Company LimitedCompletedType2 Diabetes MellitusUnited States
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Janssen Sciences Ireland UCCompletedHIV-1United States, South Africa, Ukraine, Kenya, Thailand, India, Romania, Uganda
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | Neurofibromatosis Type 1Canada, United States
-
Hoffmann-La RocheRecruitingCarcinoma, HepatocellularKorea, Republic of, Taiwan, United States, France, Spain, New Zealand, United Kingdom
-
Genentech, Inc.Chugai Pharmaceutical Co.RecruitingGastric Cancer | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaKorea, Republic of, Spain, Japan, New Zealand, Australia, United States, Italy, Brazil
-
Gilead SciencesCompletedHIV-1 InfectionUnited States, Spain, United Kingdom, Canada, Puerto Rico, France, Belgium, Italy, Germany, Austria
-
German Diabetes CenterYale UniversityEnrolling by invitationType2 DiabetesGermany